Evidence-based articles, treatment guides, and the latest news in addiction recovery and mental health.
Three dead and 25 exposed including 18 first responders in Mountainair, New Mexico, revealing the escalating risks of potent fentanyl analogs
Single dose of psilocybin with therapy support produced rapid, sustained reductions in suicidal thoughts among treatment-resistant patients
The Department of Veterans Affairs begins groundbreaking clinical trial testing MDMA-assisted therapy for veterans struggling with PTSD and alcohol use disorder, marking a significant federal investment in psychedelic medicine.
The Virginia Harm Reduction Coalition deploys distinctive purple dispensing boxes across Southwest Virginia, making life-saving naloxone freely available in communities with some of the state's highest overdose rates.
New research reveals how cAMP signaling in brain neurons drives GLP-1 weight loss effects, opening pathways to enhance addiction treatments.
University of Reading study finds single psilocybin dose reduces neuropathic pain for weeks and makes standard painkillers work better.
While overdose deaths fell 15% nationwide, Colorado and several Western states saw increases driven by fentanyl-methamphetamine combinations.
New real-world evidence shows extended-release buprenorphine significantly outperforms other medication-assisted treatments in preventing relapse and reducing healthcare costs.
Research published in the American Journal of Preventive Medicine reveals rising barriers to timely care for adolescents with cannabis use disorder, with younger teens and males most affected.